FLT3 and acute myeloid leukemia: In AML, some mutations are also associated with intracellular metabolic changes, such as internal tandem duplication (ITD) mutations of FLT3 associated with increased glycolytic activity through the upregulation of the gatekeeper glycolytic enzyme hexokinase 2 (HK-2) [191].